These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 27044550)
1. Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates. Choi MJ; Won EJ; Shin JH; Kim SH; Lee WG; Kim MN; Lee K; Shin MG; Suh SP; Ryang DW; Im YJ Antimicrob Agents Chemother; 2016 Jun; 60(6):3653-61. PubMed ID: 27044550 [TBL] [Abstract][Full Text] [Related]
2. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates. Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565 [TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China. Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420 [TBL] [Abstract][Full Text] [Related]
4. Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis. Berkow EL; Manigaba K; Parker JE; Barker KS; Kelly SL; Rogers PD Antimicrob Agents Chemother; 2015 Oct; 59(10):5942-50. PubMed ID: 26169412 [TBL] [Abstract][Full Text] [Related]
5. Analysis of CDR1 and MDR1 Gene Expression and ERG11 Substitutions in Clinical Candida tropicalis Isolates from Alexandria, Egypt. El-Kholy MA; Helaly GF; El Ghazzawi EF; El-Sawaf G; Shawky SM Braz J Microbiol; 2023 Dec; 54(4):2609-2615. PubMed ID: 37606863 [TBL] [Abstract][Full Text] [Related]
6. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Sanglard D; Coste AT Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310 [TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India. Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals. Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718 [TBL] [Abstract][Full Text] [Related]
9. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination. Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783 [TBL] [Abstract][Full Text] [Related]
10. The A395T mutation in ERG11 gene confers fluconazole resistance in Candida tropicalis causing candidemia. Tan J; Zhang J; Chen W; Sun Y; Wan Z; Li R; Liu W Mycopathologia; 2015 Apr; 179(3-4):213-8. PubMed ID: 25398256 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of efflux pump transporter genes and mutations in ERG11 pave the way to fluconazole resistance in Candida tropicalis: A study from a North India region. Pandey N; Tripathi M; Gupta MK; Tilak R J Glob Antimicrob Resist; 2020 Sep; 22():374-378. PubMed ID: 32084606 [TBL] [Abstract][Full Text] [Related]
12. ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates. Xu Y; Sheng F; Zhao J; Chen L; Li C Arch Microbiol; 2015 Nov; 197(9):1087-93. PubMed ID: 26349561 [TBL] [Abstract][Full Text] [Related]
13. An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans. Heilmann CJ; Schneider S; Barker KS; Rogers PD; Morschhäuser J Antimicrob Agents Chemother; 2010 Jan; 54(1):353-9. PubMed ID: 19884367 [TBL] [Abstract][Full Text] [Related]
14. Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India. Singh A; Singh PK; de Groot T; Kumar A; Mathur P; Tarai B; Sachdeva N; Upadhyaya G; Sarma S; Meis JF; Chowdhary A J Antimicrob Chemother; 2019 May; 74(5):1260-1268. PubMed ID: 30753525 [TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanisms of fluconazole resistance in clinical isolates of Candida glabrata]. Shen YZ; Lu HZ; Zhang YX Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):245-9. PubMed ID: 20450660 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of berberine-mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates. Shi G; Shao J; Wang T; Wu D; Wang C Biomed Pharmacother; 2017 Sep; 93():709-712. PubMed ID: 28700974 [TBL] [Abstract][Full Text] [Related]
17. You L; Qian W; Yang Q; Mao L; Zhu L; Huang X; Jin J; Meng H Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28507109 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait. Asadzadeh M; Ahmad S; Al-Sweih N; Khan Z Microb Drug Resist; 2017 Dec; 23(8):966-972. PubMed ID: 28353392 [TBL] [Abstract][Full Text] [Related]
19. Drug resistance genes and trailing growth in Candida albicans isolates. Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046 [TBL] [Abstract][Full Text] [Related]
20. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans. Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]